期刊文献+

糖尿病肾病足细胞损伤病理机制及信号通路的研究进展 被引量:12

Research progress in pathological mechanism and related signaling pathways of podocyte injury in diabetic nephropathy
下载PDF
导出
摘要 糖尿病肾病(DN)是糖尿病最常见的微血管并发症,是终末期肾病的重要的病因之一。关于DN发病机制,最新研究发现,足细胞损伤在DN的病程中起到至关重要的作用,主要包括足细胞肥大、上皮间充质转化(EMT)、足细胞凋亡和足细胞自噬,且多个肾脏信号通路的破坏在这些病理损伤的进展中至关重要,例如腺苷单磷酸活化激酶信号通路(AMPK)、Wnt/β-catenin信号通路、内质网应激相关信号通路等。本文从糖尿病肾病足细胞损伤病理机制及信号通路的研究进展作为出发点,进一步了解分子机制方面糖尿病肾病足细胞损伤。 Diabetic nephropathy(DN) is the most common microvascular complication of diabetes and one of the important causes of end-stage renal disease. Regarding the pathogenesis of DN, more and more scholars have recently found that podocyte injury plays a crucial role in the course of DN, including podocyte hypertrophy, epithelial-mesenchymal transition(EMT), podocyte apoptosis, and podocyte autophagy, and disruption of multiple renal signaling pathways are critical in the progression of these pathological lesions, such as adenosine monophosphate-activated kinase signaling(AMPK), Wnt/β-catenin signaling, endoplasmic Network stress-related signaling pathways. This article aims to further understand the molecular mechanism of podocyte injury in diabetic nephropathy from the research progress in the pathological mechanism and signaling pathway of podocyte injury in diabetic nephropathy.
作者 王晨曦(综述) 王子瑞 俞澜(审校) WANG Chen-xi;WANG Zi-rui;YU Lan(Northwest Minzu University,Lanzhou 730000,Gansu,CHINA;Gansu Second People's Hospital,Lanzhou 730000,Gansu,CHINA)
出处 《海南医学》 CAS 2023年第1期130-135,共6页 Hainan Medical Journal
基金 中央高校青年教师创新项目(编号:31920210049)。
关键词 糖尿病肾病 足细胞损伤 自噬 凋亡 信号通路 Diabetic nephropathy Podocyte injury Autophagy Apoptosis Signal pathway
  • 相关文献

参考文献6

二级参考文献78

  • 1杨倩,梁伟,丁国华.足细胞损伤与糖尿病肾病[J].中国医学前沿杂志(电子版),2012,4(9):10-14. 被引量:4
  • 2Montserrat B Duran-Salgado,Alberto F Rubio-Guerra.Diabetic nephropathy and inflammation[J].World Journal of Diabetes,2014,5(3):393-398. 被引量:178
  • 3张瑜,周建华,王洪涛.乙型肝炎病毒相关性膜性肾病患儿足细胞缺失的研究[J].中华儿科杂志,2007,45(5):344-348. 被引量:15
  • 4Loeffler I, Wolf G. Epithelial-to-mesenchymal transition in diabet- ic nephropathy:fact or fiction.'? [J]. Cells,2015,4(4) :631.
  • 5Mathieson P W. The podocyte as a target for therapies and old [ J ]. Nat Rev Nepbrol,2011,8 ( 1 ) :52.
  • 6Li J J,Kwak S J,Jung D S,et al. Podocyte biology in diabetic ne- phropathy [ J ]. Kidney Int Suppl, 2007 ( 106 ) : $36.
  • 7Cellesi F, Li M, Rastaldi M P. Podocyte injury and repair mecha- nisms[J]. Curr Opin Nephrol Hypertens,2015,24(3) :239.
  • 8浅沼克彦,日高輝夫,富野康日己.腎障害におけるポドサイトの役割[J].日内会誌,2012,101 (4) : 1092.
  • 9Blacklock C L, Hirst J A,Taylor K S, et al. Evidence for a dose effect of renin-angiotensin system inhibition on progression of mi- croalbuminuria in type 2 diabetes : a Meta-analysis [ J 1 DiabetMed,2011,28(10) :1182.
  • 10Kohan D E, Pritchett Y, Molitch M, et al. Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in dia- betic nephropathy[J]. J Am Soc Nephrol,2011,22(4) :763.

共引文献117

同被引文献204

引证文献12

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部